)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Vimian Group
Vimian Group (VIMIAN) investor relations material
Vimian Group Q3 2026 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 earnings summary22 Oct, 2026
Executive summary
Q3 revenue rose 15% YoY to €120.3m, including 11% organic growth; adjusted EBITA increased 14% to €29.2m.
Organic growth was positive across all four segments, and adjusted EBITA increased in each segment.
Operating cash flow reached €22.6m; net debt fell to €262.4m and leverage to 2.0x.
Financial highlights
Q3 EBIT increased to €20.5m from €17.5m; profit for the period was €9.3m versus €6.8m, and diluted EPS was €0.02 versus €0.01.
Adjusted EBITA margin was 24.3% versus 24.5%; EBIT margin was 17.0% versus 16.8%.
Net financial items were -€6.9m, including €4.2m financing expense, €2.2m negative contingent-consideration adjustments and €0.5m negative FX impact.
Tax expense was €4.3m, with a 31% effective rate; contingent-consideration adjustments and other non-deductible expenses affected the rate.
Nine-month revenue rose 13% to €357.9m and adjusted EBITA increased 11% to €88.1m.
Outlook and guidance
Management expects sustainable, volume-led growth alongside value-creating M&A; a Capital Markets Day on 24 November 2026 will detail strategy and the 2030 target roadmap.
FY2026 margin development is expected to be more stable than FY2025; MedTech investments are expected to cause a slight full-year segment margin decline.
U.S. Orthopedics is expected to maintain low-single-digit Q4 growth under unchanged market conditions; higher growth depends on market improvement in 2027 or later.
Veterinary Services Q4 margin is expected at 28.5%–29%, in line with its YTD average.
Diagnostics margins are expected to improve as companion-animal business scales, with a pickup anticipated from 2027 onward.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Vimian Group
- Double-digit revenue and earnings growth in Q2 2026, with robust M&A and margin expansion.VIMIAN
Q2 2026 - Double-digit organic growth and acquisitions drove higher revenue, profit, and cash flow.VIMIANQ1 2026
- Revenue up 13% to EUR 425m, adjusted EBITA up 11%, strong cash flow, no 2025 dividend.VIMIANQ4 2025
- Revenue up 15% with strong cash flow, but MedTech organic sales declined in a soft US market.VIMIANQ2 2025
- Aims for €300M EBITDA by 2030 via innovation, M&A, and global expansion in animal health niches.VIMIANJefferies London Healthcare Conference 2024
- Double-digit growth, margin expansion, and MedTech dental acquisition highlight Q3.VIMIANQ3 2024
- Q2 saw double-digit growth, margin gains, and leverage cut to 1.4x after a capital raise.VIMIANQ2 2024
- Q1 2025 saw 18% revenue growth, margin stability, and improved leverage despite US MedTech softness.VIMIANQ1 2025
- Record revenue, strong growth, and improved cash flow despite US MedTech challenges.VIMIANQ4 2024
Next Vimian Group earnings date
CMD 202624 Nov, 2026
Vimian Group
Next Vimian Group earnings date
CMD 202624 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Vimian Group AB, a Swedish-based animal health company, engages in the animal health business worldwide. The company offers pharmaceutical products for use against parasites in pets and livestock, which are distributed to veterinarians, pet shops, and wholesalers through its international distribution network. Vimian Group is based in Stockholm, Sweden.